'We were trying to build the plane at the same time as flying it,' says Biogen on Alzheimer's research
Previous setbacks in Alzheimer’s disease research for disease-modifying treatments have set the stage for a pipeline of new medicines now moving into clinical trials, according to a recent PhRMA report.